4.2 Article

In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases

Journal

NEUROPATHOLOGY
Volume 29, Issue 4, Pages 433-442

Publisher

WILEY
DOI: 10.1111/j.1440-1789.2008.00996.x

Keywords

HIV encephalitis; HIVp24; IL-1 beta; multinucleated giant cells; TNF-alpha

Funding

  1. Ministry of Health, Labour, and Welfare in Japan

Ask authors/readers for more resources

As the pathogenesis of AIDS dementia complex (ADC), cytokines such as TNF-alpha and IL-1 beta have been thought to have toxic effects on CNS cells and induce neuronal cell death. However, many of the discussions have been based on the studies done by in vitro experiments. There are only a few reports which demonstrate proinflammatory cytokines directly in vivo in HIV encephalitis (HIVE) brains, and roles of these cytokines with relation to HIV-1 infection are not yet clarified. In the present study, we examined 11 autopsy cases of HIVE using immunohistochemistry, and explored which cell types expressed these cytokines and whether expression of cytokines was related to viral infection. IL-1 beta was detected in the frontal white matter of all 11 cases where microglial nodules were observed to varying degrees, whereas TNF-alpha was detected in seven cases. IL-1 beta- or TNF-alpha-positive cells were almost restricted to CD68-positive macrophages/microglia and mild expression of these cytokines by astrocytes was observed in two cases with severe HIVE. IL-1 beta was detected in some HIVp24-positive multinucleated giant cells. However, we could not detect TNF-alpha expression in the HIVp24-positive cells, which indicates that IL-1 beta is induced by HIV-1 infection. In conclusion, a macrophage/microglia lineage is the main cell type to release cytokines in HIVE, and IL-1 beta expression by HIV-1-infected cells may be one of the important factors for induction of HIVE. In addition, many non-infected macrophages/microglia as well as some astrocytes express IL-1 beta and TNF-alpha, which might contribute to pathogenesis of ADC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy

Ellen Gelpi, Jasmin Rahimi, Sigrid Klotz, Susanne Schmid, Gerda Ricken, Sara Forcen-Vega, Herbert Budka, Gabor G. Kovacs

NEUROPATHOLOGY (2020)

Article Infectious Diseases

Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis

Daisuke Kodama, Masakazu Tanaka, Toshio Matsuzaki, Kimiko Izumo, Nobuaki Nakano, Eiji Matsuura, Mineki Saito, Masahiro Nagai, Masahisa Horiuchi, Atae Utsunomiya, Hiroshi Takashima, Ryuji Kubota, Shuji Izumo

PLOS NEGLECTED TROPICAL DISEASES (2020)

Article Clinical Neurology

Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study

Emma Jones, Holger Hummerich, Emmanuelle Vir, James Uphill, Athanasios Dimitriadis, Helen Speedy, Tracy Campbell, Penny Norsworthy, Liam Quinn, Jerome Whitfield, Jacqueline Linehan, Zane Jaunmuktane, Sebastian Brandner, Parmjit Jat, Akin Nihat, Tze How Mok, Parvin Ahmed, Steven Collins, Christiane Stehmann, Shannon Sarros, Gabor G. Kovacs, Michael D. Geschwind, Aili Golubjatnikov, Karl Frontzek, Herbert Budka, Adriano Aguzzi, Hata Karamujic-Comic, Sven J. van der Lee, Carla A. Ibrahim-Verbaas, Cornelia M. van Duijn, Beata Sikorska, Ewa Golanska, Pawel P. Liberski, Miguel Calero, Olga Calero, Pascual Sanchez-Juan, Antonio Salas, Federico Martinon-Torres, Elodie Bouaziz-Amar, Stephane Haik, Jean-Louis Laplanche, Jean-Phillipe Brandel, Phillipe Amouyel, Jean-Charles Lambert, Piero Parchi, Anna Bartoletti-Stella, Sabina Capellari, Anna Poleggi, Anna Ladogana, Maurizio Pocchiari, Serena Aneli, Giuseppe Matullo, Richard Knight, Saima Zafar, Inga Zerr, Stephanie Booth, Michael B. Coulthart, Gerard H. Jansen, Katie Glisic, Janis Blevins, Pierluigi Gambetti, Jiri Safar, Brian Appleby, John Collinge, Simon Mead

LANCET NEUROLOGY (2020)

Article Clinical Neurology

Co-incidental C9orf72 expansion mutation-related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt-Jakob disease

Sigrid Klotz, Theresa Konig, Marcus Erdler, Andreas Ulram, Anita Nguyen, Thomas Strobel, Alexander Zimprich, Elisabeth Stogmann, Gunther Regelsberger, Romana Hoftberger, Herbert Budka, Gabor G. Kovacs, Ellen Gelpi

Summary: This study presents a rare case of a patient with both C9orf72 expansion mutation-related frontotemporal lobe degeneration and sporadic Creutzfeldt-Jakob disease. The neuropathology exhibited multiple protein aggregates along with a high degree of Alzheimer-related pathology. Further studies are needed to investigate a potential link between these two neurodegenerative pathologies.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Microbiology

Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

Daisuke Kodama, Masakazu Tanaka, Toshio Matsuzaki, Satoshi Nozuma, Eiji Matsuura, Hiroshi Takashima, Shuji Izumo, Ryuji Kubota

Summary: The study compared the performance of different detection methods in the CSF of HAM/TSP patients and HTLV-1 carriers, demonstrating that CLIA was closer to PA in performance, while CLEIA had lower sensitivity.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Virology

Histotype-Dependent Oligodendroglial PrP Pathology in Sporadic CJD: A Frequent Feature of the M2C Strain

Ellen Gelpi, Sigrid Klotz, Nuria Vidal-Robau, Gerda Ricken, Gunther Regelsberger, Thomas Strobel, Ognian Kalev, Marlene Leoni, Herbert Budka, Gabor G. Kovacs

Summary: The study found that in sporadic Creutzfeldt-Jakob disease, the MM2C subtype is more likely to accumulate PrPd in white matter oligodendrocytes, and this pathology is more prominent in patients with a longer disease duration.

VIRUSES-BASEL (2021)

Article Immunology

High Prevalence of HTLV-1 Carriers Among the Elderly Population in Kagoshima, a Highly Endemic Area in Japan

Yuichi Tashiro, Eiji Matsuura, Yasuko Sagara, Satoshi Nozuma, Daisuke Kodama, Masakazu Tanaka, Chihaya Koriyama, Ryuji Kubota, Hiroshi Takashima

Summary: Japan is a highly endemic area for HTLV-1, and the infection rate increases with age. This study estimated the number and rate of HTLV-1 infection in Kagoshima using preoperative screening data. The results showed a high infection rate among the elderly, suggesting that the infection risk may have been present since infancy.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2022)

Article Neurosciences

Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease

Ellen Gelpi, Simone Baiardi, Carlos Nos, Sofia Dellavalle, Iban Aldecoa, Raquel Ruiz-Garcia, Lourdes Ispierto, Domingo Escudero, Virgina Casado, Elena Barranco, Anuncia Boltes, Laura Molina-Porcel, Nuria Bargallo, Marcello Rossi, Angela Mammana, Dorina Tiple, Luana Vaianella, Elisabeth Stoegmann, Ingrid Simonitsch-Klupp, Gregor Kasprian, Sigrid Klotz, Romana Hoeftberger, Herbert Budka, Gabor G. Kovacs, Isidre Ferrer, Sabina Capellari, Raquel Sanchez-Valle, Piero Parchi

Summary: This study identified a new subtype of sCJD with clinicopathological features significantly overlapping with those of the VV1 subtype, possibly representing the missing evidence of V1 sCJD strain propagation in the 129MV host genotype.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Clinical Neurology

Efficacy of l-Arginine treatment in patients with HTLV-1-associated neurological disease

Satoshi Nozuma, Eiji Matsuura, Yuichi Tashiro, Ryusei Nagata, Masahiro Ando, Yu Hiramatsu, Yujiro Higuchi, Yusuke Sakiyama, Akihiro Hashiguchi, Kumiko Michizono, Keiko Higashi, Toshio Matsuzaki, Daisuke Kodama, Masakazu Tanaka, Yoshihisa Yamano, Takashi Moritoyo, Ryuji Kubota, Hiroshi Takashima

Summary: This study evaluated the efficacy and safety of l-arginine in patients with HAM/TSP. The results showed that l-arginine therapy improved motor function and reduced inflammatory markers in the cerebrospinal fluid. Therefore, l-arginine may be a promising therapeutic option for patients with HAM/TSP.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Article Orthopedics

HTLV-1-associated myelopathy/tropical spastic paraplegia with sporadic late-onset nemaline myopathy: a case report

Eiji Matsuura, Satoshi Nozuma, Ayano Shigehisa, Mika Dozono, Tomonori Nakamura, Masakazu Tanaka, Ryuji Kubota, Akihiro Hashiguchi, Hiroshi Takashima

Summary: This case report describes a rare association between HTLV-1 infection and sporadic late onset nemaline myopathy (SLONM). Further studies are needed to understand the relationship between retroviruses and muscle diseases.

BMC MUSCULOSKELETAL DISORDERS (2023)

Article Virology

Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence

Ellen Gelpi, Sigrid Klotz, Miriam Beyerle, Sven Wischnewski, Verena Harter, Harald Kirschner, Katharina Stolz, Christoph Reisinger, Elisabeth Lindeck-Pozza, Alexander Zoufaly, Marlene Leoni, Gregor Gorkiewicz, Martin Zacharias, Christine Haberler, Johannes Hainfellner, Adelheid Woehrer, Simon Hametner, Thomas Roetzer, Till Voigtlaender, Gerda Ricken, Verena Endmayr, Carmen Haider, Judith Ludwig, Andrea Polt, Gloria Wilk, Susanne Schmid, Irene Erben, Anita Nguyen, Susanna Lang, Ingrid Simonitsch-Klupp, Christoph Kornauth, Maja Nackenhorst, Johannes Klaeger, Renate Kain, Andreas Chott, Richard Wasicky, Robert Krause, Guenter Weiss, Judith Loeffler-Rag, Thomas Berger, Patrizia Moser, Afshin Soleiman, Martin Asslaber, Roland Sedivy, Nikolaus Klupp, Martin Klimpfinger, Daniele Risser, Herbert Budka, Lucas Schirmer, Anne-Katrin Probstel, Romana Hoeftberger

Summary: We conducted a neuropathological analysis on 32 patients who died from COVID-19 in Austria between 2020 and 2021. The results showed diffuse white matter damage and microglial activation in all cases, indicating indirect brain damage rather than direct virus-specific damage. Inflammatory changes and vascular pathologies were also observed, along with silent neurodegenerative pathologies in elderly patients. These findings align with experimental data on SARS-CoV-2-related brain damage and provide a better understanding of the mechanisms underlying neurological symptoms after COVID-19.

VIRUSES-BASEL (2023)

Article Clinical Neurology

Anti-ganglionic acetylcholine receptor antibodies in functional neurological symptom disorder/conversion disorder

Ryusei Nagata, Eiji Matsuura, Satoshi Nozuma, Mika Dozono, Yutaka Noguchi, Masahiro Ando, Yu Hiramatsu, Daisuke Kodama, Masakazu Tanaka, Ryuji Kubota, Munekazu Yamakuchi, Yujiro Higuchi, Yusuke Sakiyama, Hitoshi Arata, Keiko Higashi, Teruto Hashiguchi, Shunya Nakane, Hiroshi Takashima

Summary: This study investigated the correlation between the presence of serum anti-ganglionic acetylcholine receptor (gAChR) antibodies and autonomic symptoms in patients with functional neurological symptom disorder/conversion disorder (FNSD/CD). The results showed that among the 59 FNSD/CD patients, 88.1% exhibited autonomic disturbances and 27.1% were positive for serum anti-gAChR antibodies. Patients positive for anti-gAChR antibodies had a higher prevalence of cardiovascular autonomic dysfunction but a lower prevalence of involuntary movements compared to antibody-negative patients. The findings suggest that an autoimmune mechanism mediated by anti-gAChR antibodies may be involved in the etiology of FNSD/CD in a subgroup of patients.

FRONTIERS IN NEUROLOGY (2023)

Article Medicine, Research & Experimental

Identification and tracking of HTLV-1-infected T cell clones in virus-associated neurologic disease

Satoshi Nozuma, Eiji Matsuura, Masakazu Tanaka, Daisuke Kodama, Toshio Matsuzaki, Akiko Yoshimura, Yusuke Sakiyama, Shingo Nakahata, Kazuhiro Morishita, Yoshimi Enose-Akahata, Steven Jacoboson, Ryuji Kubota, Hiroshi Takashima

Summary: This study demonstrates that analyzing TCR repertoires of HTLV-1-infected cells can provide insights into the clonal dynamics and potential pathogenic clones expanded in the CNS of HAM/TSP patients. The TCR beta repertoire analysis reveals a higher clonal expansion in HTLV-1-infected cells compared to noninfected cells, and the TCR sequences of infected cells remain stable over time. Furthermore, highly expanded infected clones are found in the cerebrospinal fluid of HAM/TSP patients.

JCI INSIGHT (2023)

Article Microbiology

Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)

Eiji Matsuura, Satoshi Nozuma, Mika Dozono, Daisuke Kodama, Masakazu Tanaka, Ryuji Kubota, Hiroshi Takashima

Summary: HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a slowly progressive neurological disease caused by HTLV-1 infection. The most common clinical manifestations of HAM/TSP include weakness of the proximal muscles of the lower extremities and atrophy of the paraspinal muscles, with the upper extremities being mostly unaffected. This study aimed to identify the muscle involvement pattern in HAM/TSP to aid diagnosis, rehabilitation and understanding of its pathogenesis.

PATHOGENS (2023)

No Data Available